Regentis Biomaterials RGNT Balance Sheet (2024-2025)

NYSE RGNT
$2.13 +0.07 (+3.41%)
As of: Aug 21, 2026 · 1:48 PM EDT
1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Dec2024 Dec2025
Assets
Current Assets
Cash & Equivalents (Quarter) 0.23M7.38M
Cash & Current Investments (Quarter) 0.23M7.38M
Prepaid Assets (Quarter) 0.25M0.24M
Non-Current Assets
Long-Term Deferred Tax (Quarter) 38.94M48.30M
Assets (Quarter) 0.48M7.62M
Liabilities
Current Liabilities
Accounts Payables (Quarter) 1.13M1.41M
Notes Payables (Quarter) 0.57M1.20M
Payables (Quarter) 1.70M2.61M
Accumulated Expenses (Quarter) 0.00M1.39M
Short term Debt (Quarter) 0.57M1.20M
Total Current Liabilities (Quarter) 6.49M2.87M
Non-Current Liabilities
Preferred Stock Liabilities (Quarter) 35.10M
Other Non-Current Liabilities (Quarter) 0.16M
Total Non-Current Liabilities (Quarter) 6.33M
Total Liabilities (Quarter) 6.49M2.87M
Shareholder's Equity
Total Debt (Quarter) 0.57M1.20M
Common Equity (Quarter) -41.10M4.74M
Liabilities and Shareholders Equity (Quarter) 0.48M7.62M
Retained Earnings (Quarter) -42.15M-55.79M
Treasury Shares (Quarter) 0.68M